IL33 and infectious disease: Indeed, while IL-33 was originally described as an inducer of type 2 immune responses, its pleiotropic nature is now well documented, including in inducing type 1 responses, and exogenous systemic IL-33 treatment may either protect or exacerbate infections, depending on the infectious disease (for review [21]).